Today: 13 June 2026
Micron stock price rises as chip trade steadies ahead of Nvidia earnings

Micron stock price rises as chip trade steadies ahead of Nvidia earnings

New York, Feb 24, 2026, 10:10 EST — Regular session

  • Micron shares climb roughly 1.5% in early trading, picking up on strength across the semiconductor space.
  • All eyes are now on Nvidia’s earnings due Wednesday, with attention shifting to those massive AI hardware deals.
  • Tariff worries linger over the tape following Monday’s selloff.

Micron Technology Inc picked up roughly 1.5%, reaching $427.08 early Tuesday, bouncing back after U.S. stocks took a hit from tariffs the previous day. Shares have already soared about 50% since the start of the year—investors aren’t exactly forgiving when it comes to negative headlines.

Micron finds itself right at the center of the memory chip crunch that’s hitting AI server supply. For traders, the stock has become a go-to proxy: a liquid bet on whether Big Tech’s appetite for spending will power through 2026, or if the momentum is beginning to slip.

Little action on Wall Street just after the bell. As of 9:31 a.m. ET, the Dow hovered near the unchanged mark, S&P 500 slipped 0.1%, and the Nasdaq barely budged, according to Reuters data.

A renewed sense of optimism around chips got a boost after AMD announced it could sell as much as $60 billion in AI semiconductors to Meta Platforms over five years. The deal hands Meta the right to carve out a significant equity position as well. “Meta is locking in supply,” Hargreaves Lansdown’s senior equity analyst Matt Britzman said. Reuters

Micron investors are working a simple equation, but the clock isn’t always clear: ramp up AI processors, and memory demand jumps too. High-bandwidth memory—HBM for short—sits right at the heart of the action. This stacked, high-speed DRAM rides next to cutting-edge AI chips, pushing data faster, and right now it’s among the most constrained parts of the supply chain.

Nvidia’s Wednesday earnings loom large, with traders watching closely to gauge if profit and demand are still stacking up fast enough to justify stretched valuations. “People are so concerned about AI spending — whether we’re in a bubble,” Spear Invest CIO Ivana Delevska told Reuters. Supply issues could also cap any upside, Seaport Research Partners’ Jay Goldberg warned. Reuters

Even so, Micron isn’t isolated. Fresh U.S. tariffs, along with the ongoing legal tussles over them, have nudged investors toward a more cautious stance—pulling back positions rather than waiting for clarity. “Uncertainty remains high,” Nationwide chief market strategist Mark Hackett said following Monday’s drop. Reuters

This is key in memory, a notoriously cyclical business where prices reverse fast if demand softens. Should AI capex stall or customers slow their rollouts, the margin tailwind from tight supply can vanish, and the stock could get hit just as quickly.

Micron faces its own execution challenges, regardless of broader market strength. Rivals like Samsung Electronics and SK Hynix keep ramping up their AI memory efforts, so if Micron stumbles on adoption rates or if supply ticks higher, expectations could shift quickly.

Eyes now turn to Nvidia’s numbers dropping Wednesday, with the company’s call expected to fuel the back-and-forth over AI demand, supply-chain issues, and where chips go from here as spring approaches. Nvidia has scheduled its quarterly results discussion for Feb. 25, 5 p.m. ET.

Stock Market Today

  • CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts
    June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL's operational turnaround prospects. The market now awaits CSL's full-year results and dividend update on 18 August 2026, which will offer clarity on revenue trends and any further impairments. CSL projects FY29 revenue of US$16.9 billion and earnings of US$3.3 billion, suggesting a potential 31% upside to current share prices. However, risks remain around sustained margin pressure and additional write-downs in plasma and albumin segments.

Latest articles

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 13.06.2026

13 June 2026
LIVEMarkets rolling coverageStarted: June 13, 2026, 4:00 AM EDTUpdated: June 13, 2026, 6:10 AM EDT CSL Shares Rise 9.8% After FY26 Guidance Cut on Impairments and Channel Shifts June 13, 2026, 5:50 AM EDT. CSL (ASX:CSL) shares climbed 9.8% following a downward revision of its FY26 revenue and profit forecasts. The revision reflects impairments and writedowns linked to changes in U.S. immunoglobulin sales channels and weakening albumin prices in China. Despite these challenges, investor sentiment shows cautious optimism about CSL’s operational turnaround prospects. The market now awaits CSL’s full-year results and dividend update on 18 August 2026, which will offer
SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

SGH Limited Holds Back as ASX 200 Pushes Higher Before FY26 Results

13 June 2026
SGH closed at A$41.51, up 0.70% but underperformed the S&P/ASX 200’s 1.98% surge, as investors weighed solid cash flow and Boral margin gains against a high 36.03 P/E, mixed demand, and M&A risk; the next key catalyst is FY26 results on August 11, with analysts’ average target at A$47.64, 14.76% above Friday’s close.
Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names
Previous Story

Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

IBM stock price rebounds after Anthropic’s COBOL claim rattles mainframe bulls
Next Story

IBM stock price rebounds after Anthropic’s COBOL claim rattles mainframe bulls

Go toTop